Figure 1.

Flow chart depicting the screening of gastric cancer patients who received sintilimab combined with chemotherapy. PD-1: Programmed cell death protein 1; PD-L1: Programmed cell death ligand 1; TyG: Triglyceride glucose.

Flow chart depicting the screening of gastric cancer patients who received sintilimab combined with chemotherapy. PD-1: Programmed cell death protein 1; PD-L1: Programmed cell death ligand 1; TyG: Triglyceride glucose.